DBVT

#2027
DBV Technologies S.A. - American Depositary Shares
19.1 0 USD
+0.79%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
19.10
19.10
Rango anual
7.53
26.19
Cambio diario
+0.79%
Variación mensual
-8.35%
Variación en los últimos 6 meses
+43.07%
Cambio anual
+123.13%
Cierres anteriores
18.9 5
Open
19.1 0
Mínimo
19.1 0
High
19.1 0
Volumen
10
Ver el calendario completo Full chart

Financials

Visión general Informes Estadísticas
Trimestre Año
  • Market Capitalization 1.13 B
  • Employee 161
  • Founded 2002
  • CEO N/A
  • Website www.dbv-technologies.com
  • Headquarter France
  • FIGI BBG0076D3T39
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-18.26
Relación precio/flujo de caja
474.74

DBV Technologies S.A. - American Depositary Shares

DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration.

Noticias